✦ LIBER ✦

Combination of intravenous pulses of cyclophosphamide and methylprednizolone in patients with systemic sclerosis and interstitial lung disease

✍ Scribed by George Yiannopoulos; Vassilios Pastromas; Ioannis Antonopoulos; George Katsiberis; George Kalliolias; Stamatis-Nick Liossis; Andrew P. Andonopoulos

Publisher: Springer
Year: 2006
Tongue: English
Weight: 256 KB
Volume: 27
Category: Article
ISSN: 0172-8172
DOI: 10.1007/s00296-006-0217-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Outcome of systemic sclerosis associated

Outcome of systemic sclerosis associated interstitial lung disease treated with intravenous cyclophosphamide

✍ Abhishek Abhishek; Ramin Yazdani; Fiona Pearce; Marian Regan; Ken Lim; Richard H 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 167 KB

Treatment of Lupus Interstitial Lung Dis

Treatment of Lupus Interstitial Lung Disease with Intravenous Cyclophosphamide

✍ Arnold R. Eiser; Harvey M. Shanies 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 412 KB 👁 1 views

Intravenous pulse cyclophosphamide (IPC) was used to treat lupus interstitial lung disease in 2 patients. Vital capacity increased by 67-110% of baseline values with IPC treatment. Total lung capacity and diffusing capacity also improved. Dyspnea and other manifestations of lupus improved dramatical

Efficacy and safety of intravenous cyclo

Efficacy and safety of intravenous cyclophosphamide pulse therapy with oral prednisolone in the treatment of interstitial lung disease with systemic sclerosis: 4-year follow-up

✍ Akiko Tochimoto; Yasushi Kawaguchi; Masako Hara; Mutsuto Tateishi; Chikako Fukas 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 277 KB

Early aggressive intra-venous pulse cycl

Early aggressive intra-venous pulse cyclophosphamide therapy for interstitial lung disease in a patient with systemic sclerosis. A case report

✍ R. Peshin; L. O’Neill; P. Browne; P. O’Connell; G. Kearns 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 121 KB

Bronchoalveolar lavage cellular profiles

Bronchoalveolar lavage cellular profiles in patients with systemic sclerosis–associated interstitial lung disease are not predictive of disease progression

✍ Nicole S. L. Goh; Srihari Veeraraghavan; Sujal R. Desai; Derek Cramer; David M. 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 82 KB 👁 2 views

## Abstract ## Objective To evaluate the prognostic value of bronchoalveolar lavage (BAL) cellular profiles in patients with systemic sclerosis–associated interstitial lung disease (SSc‐ILD). ## Methods BAL cellularity was examined in relation to mortality (n = 141), serial pulmonary function fi

Association of hepatocyte growth factor

Association of hepatocyte growth factor promoter polymorphism with severity of interstitial lung disease in Japanese patients with systemic sclerosis

✍ Kana Hoshino; Takashi Satoh; Yasushi Kawaguchi; Masataka Kuwana 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 207 KB 👁 2 views